These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 9723308

  • 1. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
    Reggiani P, Rossi G, Latham L, Caccamo L, Gatti S, Maggi U, Melada E, Paone G, Doglia M, Vannelli A, Fassati LR.
    Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
    [No Abstract] [Full Text] [Related]

  • 2. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
    Melter M, Rodeck B, Kardorff R, Hoyer PF, Maibücher A, Brodehl J.
    Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
    [No Abstract] [Full Text] [Related]

  • 3. Experience with neoral cyclosporine through the oral route in liver transplantation.
    Bilbao I, Lazaro JL, Pou L, Charco R, Hildalgo E, Murio E, Margarit C.
    Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580
    [No Abstract] [Full Text] [Related]

  • 4. Low incidence of acute cellular rejection in liver transplantation with Neoral.
    Imventarza O, Lendoire J, Bianco G, Saúl J, Braslavsky G, Trigo P, Cueto G, Duek F, Aziz H.
    Transplant Proc; 1998 Aug; 30(5):1854. PubMed ID: 9723307
    [No Abstract] [Full Text] [Related]

  • 5. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
    Bilbao I, Pou L, Allende E, Lázaro JL, Charco R, Hidalgo E, Margarit C.
    Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
    [No Abstract] [Full Text] [Related]

  • 6. Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients.
    Cao S, Cox KL, Berquist W, So S, Concepcion W, Monge H, Esquivel CO.
    Transplant Proc; 1998 Dec; 30(8):4322-4. PubMed ID: 9865373
    [No Abstract] [Full Text] [Related]

  • 7. Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.
    Dibo-Cohen JM, Conort O, Conti F, Bernard D, Hazebroucq G, Calmus Y.
    Transplant Proc; 1998 Aug; 30(5):1857. PubMed ID: 9723309
    [No Abstract] [Full Text] [Related]

  • 8. Cyclosporine: the principal immunosuppressant for renal transplantation.
    Keown PA, Primmett DR.
    Transplant Proc; 1998 Aug; 30(5):1712-5. PubMed ID: 9723252
    [No Abstract] [Full Text] [Related]

  • 9. Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients.
    Baruch Y, Assy N, Kramsky R, Enat R.
    Transplant Proc; 1998 Aug; 30(5):1852-3. PubMed ID: 9723306
    [No Abstract] [Full Text] [Related]

  • 10. A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin.
    Rolles K, Davidson BR, Burroughs AK.
    Transplantation; 1999 Oct 27; 68(8):1195-8. PubMed ID: 10551650
    [Abstract] [Full Text] [Related]

  • 11. Neoral versus Sandimmun: clinical impact and modification of immunosuppressive therapy in cardiac transplantation.
    Maccherini M, Bernazzali S, Diciolla F, Giunti G, Bizzarri F, Lisi GF, Davoli G, Biagioli B, Giomarelli PP, Simeone F, Caciorgna M, Marchetti L, Pula G, Sani G, Toscano M.
    Transplant Proc; 1998 Aug 27; 30(5):1904-5. PubMed ID: 9723327
    [No Abstract] [Full Text] [Related]

  • 12. Neoral without intravenous cyclosporine in liver transplantation.
    Hemming AW, Greig PD, Cattral MS, Chung SW, Lilly LB, Aljumah AA, Levy GA.
    Transplant Proc; 1997 Aug 27; 29(1-2):543. PubMed ID: 9123121
    [No Abstract] [Full Text] [Related]

  • 13. Economic evaluation of Neoral versus Sandimmune maintenance therapy for de novo liver transplant patients: results from an International Randomized Controlled Trial. Milton Study Group.
    Peeters P, Kazek M, Abella I, Noble I.
    Transplant Proc; 1998 Aug 27; 30(5):1838-42. PubMed ID: 9723301
    [No Abstract] [Full Text] [Related]

  • 14. Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.
    Van Buren D, Payne J, Geevarghese S, MacDonell R, Chapman W, Wright JK, Helderman JH, Richie R, Pinson CW.
    Transplant Proc; 1998 Aug 27; 30(5):1830-2. PubMed ID: 9723299
    [Abstract] [Full Text] [Related]

  • 15. Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression.
    Mirza DF, Gunson BK, Soonawalla Z, Pirenne J, Mayer AD, Buckels JA, McMaster P.
    Lancet; 1997 Mar 08; 349(9053):701-2. PubMed ID: 9078209
    [No Abstract] [Full Text] [Related]

  • 16. Reduced acute rejection and side effects with neoral in liver transplantation.
    Tisone G, Vennarecci G, Pisani F, Baiocchi L, Mercadante E, Orlando G, Anselmo A, Casciani CU.
    Transplant Proc; 1998 Jun 08; 30(4):1430-1. PubMed ID: 9636579
    [No Abstract] [Full Text] [Related]

  • 17. Frequency of switch from cyclosporine to FK 506 before and after Neoral use in pediatric liver transplantation.
    Gridelli B, Colledan M, Lucianetti A, Ulla L, Riva S, Segalin A, Fassati LR, Torre G.
    Transplant Proc; 1998 Aug 08; 30(5):1861-2. PubMed ID: 9723311
    [No Abstract] [Full Text] [Related]

  • 18. NOF-11: a one-year randomized double-blind comparison of Neoral versus Sandimmune in pediatric liver transplantation.
    Alvarez F, Atkison P, Grant D, Jones A, Kim P, Kneteman N, Laurin L, Martin S, Paradis K, Shapiro J, Smith L, Superina R, Tan A.
    Transplant Proc; 1998 Aug 08; 30(5):1961. PubMed ID: 9723352
    [No Abstract] [Full Text] [Related]

  • 19. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application?
    Haller GW, Winkler M, Bechstein WO, Oldhafer KJ, Ringe B, Maibücher A, Färber L, Pichlmayr R, Neuhaus P.
    Transplant Proc; 1996 Aug 08; 28(4):2239-40. PubMed ID: 8769211
    [No Abstract] [Full Text] [Related]

  • 20. Oral vs intravenous tacrolimus-based induction therapy in renal transplantation.
    Tojimbara T, Kimikawa M, Nakajima I, Sato S, Nakamura M, Ishida H, Tanabe K, Koyama I, Utsumi K, Sannomiya A, Tsuji K, Fuchinoue S, Agishi T.
    Transplant Proc; 1999 Nov 08; 31(7):2763-4. PubMed ID: 10578282
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.